Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.
Domenico Prezioso(Federico II University Hospital), Fabrizio Iacono(Federico II University Hospital), Emanuele Annunziata, M. Di Martino, Gennaro Iapicca(Federico II University Hospital), Raffaele Galasso(University of Naples Federico II)
PubMed
May 10, 2007
Cited by 2
Related Papers
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group
|Archivio Italiano di Urologia e Andrologia|2015|202
Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study
|The Journal of Urology|2007|181
Experiments and scaling laws for catastrophic collisions
|NASA Technical Reports Server (NASA)|1989|116
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas
|International Journal of Cancer|1999|97
Italian validation of the International Consultation on Incontinence Questionnaires
|British Journal of Urology|2005|84